Positron emission tomography (PET)/Computed tomography (CT) Scan

DEVICE2 trials

Sponsors

National Institute of Mental Health (NIMH), Stanford University

Conditions

CancerHealthy VolunteersInflammatoryLung CancerMyositisRheumatoid Arthritis

Phase 1

Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions

TerminatedNCT03912428

National Institute of Mental Health (NIMH)Healthy Volunteers, Inflammatory, Myositis +1

Start: 2019-06-14End: 2024-06-14Updated: 2025-09-16

Biodistribution&Pharmacokinetic of Position Emission Tomography(PET) Radiopharmaceutical 18F C SNAT4

SuspendedNCT04017819

Stanford UniversityCancer, Lung Cancer

Start: 2024-03-07End: 2026-05-31Target: 20Updated: 2025-11-05

Related Papers

PET measurement of cyclooxygenase-2 using a novel radioligand: upregulation in primate neuroinflammation and first-in-human study.

2020-05-0245 citations